Citations

Clear

3309 citation(s) found for "Do, Alexander".

Inflammation-Induced NFATc1–STAT3 Transcription Complex Promotes Pancreatic Cancer Initiation by Kras G12D
Baumgart, Sandra, Chen, Nai-Ming, König, Alexander , Zhang, Jin‐San , Singh, Shiv K. , Wolf, Elmar , Bartkuhn, Marek , Esposito, Iréne , Heßmann, Elisabeth , Reinecke, Johanna, Nikorowitsch, Julius, Brunner, Marius , Fernández-Zapico, Martín E. , Smyrk, Thomas C. , Bamlet, William R. , Neeße, Albrecht , Gress, Thomas M. , Billadeau, Daniel D. , Ellenrieder, Volker , Siveke, Jens T. , Singh, Garima, Smyrk, Thomas, Eilers, Martin, Neesse, Albrecht, Tuveson, David, Urrutia, Raúl , Siveke, Jens , Singh, Garima Prateek , Eilers, Martin , Tuveson, David A. , Bamlet, William R , Singh, Shiv K

Mayo Clinic

Cancer Discovery | April 3, 2014 | Volume: 4 | Issue: 6 | Pages: 688-701

10.1158/2159-8290.cd-13-0593 | PMID 24694735 Get It

Abstract Cancer-associated inflammation is a molecular key feature in pancreatic ductal adenocarcinoma. Oncogenic KRAS in conjunction with persistent inflammation is known to accelerate carcinogenesis, although the underlying mechanisms remain poorly understood. Here, we outline a novel pathway whereby the transcription factors NFATc1 and STAT3 cooperate in pancreatic epithelial cells to promote KrasG12D-driven carcinogenesis. NFATc1 activation is induced by inflammation and itself accelerates inflammation-induced carcinogenesis in KrasG12D mice, whereas genetic or pharmacologic ablation of NFATc1 attenuates this effect. Mechanistically, NFATc1 complexes with STAT3 for enhancer–promoter communications at jointly regulated genes involved in oncogenesis, for example, Cyclin, EGFR and WNT family members. The NFATc1–STAT3 cooperativity is operative in pancreatitis-mediated carcinogenesis as well as in established human pancreatic cancer. Together, these studies unravel new mechanisms of inflammatory-driven pancreatic carcinogenesis and suggest beneficial effects of chemopreventive strategies using drugs that are currently available for targeting these factors in clinical trials. Significance: Our study points to the existence of an oncogenic NFATc1–STAT3 cooperativity that mechanistically links inflammation with pancreatic cancer initiation and progression. Because NFATc1–STAT3 nucleoprotein complexes control the expression of gene networks at the intersection of inflammation and cancer, our study has significant relevance for potentially managing pancreatic cancer and other inflammatory-driven malignancies. Cancer Discov; 4(6); 688–701. ©2014 AACR. This article is highlighted in the In This Issue feature, p. 621
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
Gleason, Michelle , Ross, Julie A. , Warlick, Erica D. , Wiernik, Andres , Haagenson, Michael , Lenvik, Alexander J. , Litzow, Mark R. , Epling‐Burnette, Pearlie K. , Weisdorf, Daniel J. , Vallera, Daniel A. , Miller, Jeffrey S. , Lund, Troy C. , Verneris, Michael R. , Spellman, Stephen R. , Blazar, Bruce R. , Weiner, Louis M. , Weisdorf, Dan , Miller, Jeffrey S

Mayo Clinic

Blood | March 21, 2014 | Volume: 123 | Issue: 19 | Pages: 3016-3026

10.1182/blood-2013-10-533398 | PMID 24652987 Get It

Key Points NK cells and their expression of FcRγIII (CD16) are decreased in MDS and inversely correlate with a substantial increase in MDSCs. CD16xCD33 BiKE potently activates blood and marrow MDS-NK cells at all diseases stages to lyse CD33+ MDS and CD33+ MDSC targets.
Comparative Functional Analysis of DPYD Variants of Potential Clinical Relevance to Dihydropyrimidine Dehydrogenase Activity
Offer, Steven M. , Fossum, Croix C. , Wegner, Natalie J., Stuflesser, Alexander J., Butterfield, Gabriel L. , Diasio, Robert B. , Offer, Steven M

Mayo Clinic

Cancer Research | March 20, 2014 | Volume: 74 | Issue: 9 | Pages: 2545-2554

10.1158/0008-5472.can-13-2482 | PMID 24648345 Get It

Abstract Dihydropyrimidine dehydrogenase (DPD) is the initial and rate-limiting enzyme of the uracil catabolic pathway, being critically important for inactivation of the commonly prescribed anti-cancer drug 5-fluorouracil (5-FU). DPD impairment leads to increased exposure to 5-FU and, in turn, increased anabolism of 5-FU to cytotoxic nucleotides, resulting in more severe clinical adverse effects. Numerous variants within the gene coding for DPD, DPYD, have been described, although only a few have been demonstrated to reduce DPD enzyme activity. To identify DPYD variants that alter enzyme function, we expressed 80 protein-coding variants in an isogenic mammalian system and measured their capacities to convert 5-FU to dihydro-fluorouracil, the product of DPD catabolism. The M166V, E828K, K861R, and P1023T variants exhibited significantly higher enzyme activity than wild-type DPD (120%, P = 0.025; 116%, P = 0.049; 130%, P = 0.0077; 138%, P = 0.048, respectively). Consistent with clinical association studies of 5-FU toxicity, the D949V substitution reduced enzyme activity by 41% (P = 0.0031). Enzyme activity was also significantly reduced for 30 additional variants, 19 of which had <25% activity. None of those 30 variants have been previously reported to associate with 5-FU toxicity in clinical association studies, which have been conducted primarily in populations of European ancestry. Using publicly available genotype databases, we confirmed the rarity of these variants in European populations but showed that they are detected at appreciable frequencies in other populations. These data strongly suggest that testing for the reported deficient DPYD variations could dramatically improve predictive genetic tests for 5-FU sensitivity, especially in individuals of non-European descent. Cancer Res; 74(9); 2545–54. ©2014 AACR.
Carpometacarpal Boss: An Unusual Cause of Extensor Tendon Ruptures
Ladak, Adil , Shin, Alexander Y. , Smith, Jay , Spinner, Robert J. , Shin, Alexander Y

Mayo Clinic

HAND | March 10, 2014 | Volume: 10 | Issue: 1 | Pages: 155-158

10.1007/s11552-014-9623-0 | PMID 25762892 Get It

Cigarette smoke-induced mitochondrial fragmentation and dysfunction in human airway smooth muscle
Aravamudan, Bharathi, Kiel, Alexander , Freeman, Michelle, Delmotte, P. , Vassallo, Robert , Sieck, Gary C. , Prakash, Y. S. , Thompson, Michael James , Pabelick, Christina M. , Prakash, Y S , Sieck, Gary , Vassallo, Robert , Kiel, Alexander M

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | March 8, 2014 | Volume: 306 | Issue: 9 | Pages: L840-L854

10.1152/ajplung.00155.2013 | PMID 24610934 Get It

The balance between mitochondrial fission and fusion is crucial for mitochondria to perform its normal cellular functions. We hypothesized that cigarette smoke (CS) disrupts this balance and enhances mitochondrial dysfunction in the airway. In nonasthmatic human airway smooth muscle (ASM) cells, CS extract (CSE) induced mitochondrial fragmentation and damages their networked morphology in a concentration-dependent fashion, via increased expression of mitochondrial fission protein dynamin-related protein 1 (Drp1) and decreased fusion protein mitofusin (Mfn) 2. CSE effects on Drp1 vs. Mfn2 and mitochondrial network morphology involved reactive oxygen species (ROS), activation of extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt), protein kinase C (PKC) and proteasome pathways, as well as transcriptional regulation via factors such as NF-κB and nuclear erythroid 2-related factor 2. Inhibiting Drp1 prevented CSE effects on mitochondrial networks and ROS generation, whereas blocking Mfn2 had the opposite, detrimental effect. In ASM from asmatic patients, mitochondria exhibited substantial morphological defects at baseline and showed increased Drp1 but decreased Mfn2 expression, with exacerbating effects of CSE. Overall, these results highlight the importance of mitochondrial networks and their regulation in the context of cellular changes induced by insults such as inflammation (as in asthma) or CS. Altered mitochondrial fission/fusion proteins have a further potential to influence parameters such as ROS and cell proliferation and apoptosis relevant to airway diseases.
Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant‐Associated Infection Surveillance Network (TRANSNET)
Kauffman, Carol A., Freifeld, Alison G. , Andes, David R. , Herwaldt, Loreen A. , Walker, Randall C., Alexander, Barbara D. , Anaissie, E., Benedict, Kaitlin , Ito, James I., Knapp, Katherine M. , Lyon, G. Marshall, Marr, Kieren A. , Morrison, V. A., Park, B. J., Schuster, Mindy G. , Chiller, Tom , Pappas, Peter G. , Baddley, John W. , Patterson, Thomas F.

Mayo Clinic

Transplant Infectious Disease | March 4, 2014 | Volume: 16 | Issue: 2 | Pages: 213-224

10.1111/tid.12186 | PMID 24589027 Get It

AbstractBackgroundInvasive fungal infections are a major cause of morbidity and mortality among solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients, but few data have been reported on the epidemiology of endemic fungal infections in these populations.MethodsFifteen institutions belonging to the Transplant‐Associated Infection Surveillance Network prospectively enrolled SOT and HCT recipients with histoplasmosis, blastomycosis, or coccidioidomycosis occurring between March 2001 and March 2006.ResultsA total of 70 patients (64 SOT recipients and 6 HCT recipients) had infection with an endemic mycosis, including 52 with histoplasmosis, 9 with blastomycosis, and 9 with coccidioidomycosis. The 12‐month cumulative incidence rate among SOT recipients for histoplasmosis was 0.102%. Occurrence of infection was bimodal; 28 (40%) infections occurred in the first 6 months post transplantation, and 24 (34%) occurred between 2 and 11 years post transplantation. Three patients were documented to have acquired infection from the donor organ. Seven SOT recipients with histoplasmosis and 3 with coccidioidomycosis died (16%); no HCT recipient died.ConclusionsThis 5‐year multicenter prospective surveillance study found that endemic mycoses occur uncommonly in SOT and HCT recipients, and that the period at risk extends for years after transplantation.
An experimental study to determine and correlate choline acetyltransferase assay with functional muscle testing after nerve injury
Vathana, Torpon , Nijhuis, Tim H.J., Friedrich, Patricia F. , Shin, Alexander Y. , Bishop, Allen T. , Shin, Alexander Y

Mayo Clinic

Journal of Neurosurgery | February 21, 2014 | Volume: 120 | Issue: 5 | Pages: 1125-1130

10.3171/2014.1.jns122241 | PMID 24559224 Get It

Object Choline acetyltransferase (ChAT) is an enzyme synthesized within the body of a motor neuron whose role is to form the neurotransmitter acetylcholine. Quantification of ChAT levels in motor or mixed nerves has been proposed to provide information regarding the viability of a proximal nerve stump for motor neurotization following brachial plexus injury. To do so requires information regarding normal ChAT levels and those in injured nerves, as well as the correlation of ChAT level determined at surgery with eventual motor recovery. The purpose of this study was to determine ChAT activity in the normal and injured sciatic/peroneal nerve in a rat model, evaluate the correlation between ChAT and motor recovery, find the relationship between ChAT activity and isometric muscle force, and elucidate the parallel between ChAT activity and acetylcholinesterase (AChE) activity. Methods Sixty animals were divided into 3 groups. The sciatic nerves in Group 1 were transected without repair. Nerves in Group 2 were transected and repaired. Nerves in Group 3 sustained a crush injury followed by transection and reconstruction. All animals were allowed 12 weeks of recovery followed by evaluation of ChAT levels in the peroneal nerve, correlated with measures of maximal isometric tibialis anterior muscle force and muscle weight (the operated side normalized to the control side). Karnovsky AChE staining of peroneal nerve segments was also compared with radiochemical assay of ChAT activity in the same nerve. Results A significant difference in the tibialis anterior isometric tetanic force and the tibialis anterior muscle weight index (TAMI) was noted between Group 1 and Groups 2 and 3 (p < 0.0001); no significant difference was found comparing Group 2 with Group 3. The correlation between the force measurement and the TAMI was 0.382. Both AChE measurement and ChAT activity demonstrated significantly fewer fibers in the operated nerve compared with the contralateral nerve. Intergroup variability could also be illustrated using these tests. The correlation coefficient between the isometric tetanic force measurement and the ChAT analysis in Groups 1 and 2 was 0.468. The correlation for the AChE staining and the isometric tetanic force measurement was 0.111. The correlation between the TAMI and the ChAT levels was 0.773. The correlation between the TAMI and the AChE-stained fibers was 0.640. Correlating AChE staining to the ChAT analysis produced a correlation of 0.712. Conclusions The great variability in all groups and weak correlations to the functional muscle assessments and the ChAT radiochemical assay made this technique an unreliable method of determining motor nerve viability.
Hydrochlorothiazide‐induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study
Vandell, Alexander G., McDonough, Caitrin W. , LANGAEE, T, Lucas, Angela M., Chapman, Arlene B. , Gums, John G. , Beitelshees, Amber L. , Bailey, Kent R. , Boerwinkle, Eric , Johnson, Julie A. , Beitelshees, Amber L. , Gong, Yan , Chapman, Arlene B. , Johnson, Richard J. , Turner, Stephen T. , Cooper‐DeHoff, Rhonda M.

Mayo Clinic

Journal of Internal Medicine | February 12, 2014 | Volume: 276 | Issue: 5 | Pages: 486-497

10.1111/joim.12215 | PMID 24612202 Get It

AbstractObjectiveElevations in uric acid (UA) and the associated hyperuricaemia are commonly observed secondary to treatment with thiazide diuretics. We sought to identify novel single nucleotide polymorphisms (SNPs) associated with hydrochlorothiazide (HCTZ)‐induced elevations in UA and hyperuricaemia.MethodsA genome‐wide association study of HCTZ‐induced changes in UA was performed in Caucasian and African American participants from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study who were treated with HCTZ monotherapy. Suggestive SNPs were replicated in Caucasians and African Americans from the PEAR study who were treated with HCTZ add‐on therapy. Replicated regions were followed up through expression and pathway analysis.ResultsFive unique gene regions were identified in African Americans (LUC7L2, ANKRD17/COX18, FTO, PADI4 and PARD3B), and one region was identified in Caucasians (GRIN3A). Increases in UA of up to 1.8 mg dL−1 were observed following HCTZ therapy in individuals homozygous for risk alleles, with heterozygotes displaying an intermediate phenotype. Several risk alleles were also associated with an increased risk of HCTZ‐induced clinical hyperuricaemia. A composite risk score, constructed in African Americans using the ‘top’ SNP from each gene region, was strongly associated with HCTZ‐induced UA elevations (P = 1.79 × 10−7) and explained 11% of the variability in UA response. Expression studies in RNA from whole blood revealed significant differences in expression of FTO by rs4784333 genotype. Pathway analysis showed putative connections between many of the genes identified through common microRNAs.ConclusionSeveral novel gene regions were associated with HCTZ‐induced UA elevations in African Americans (LUC7L2, COX18/ANKRD17, FTO, PADI4 and PARD3B), and one region was associated with these elevations in Caucasians (GRIN3A).
Increasing LH Pulsatility in Women With Hypothalamic Amenorrhoea Using Intravenous Infusion of Kisspeptin-54
Jayasena, Channa , Abbara, Ali , Veldhuis, Johannes D. , Comninos, Alexander , Ratnasabapathy, Risheka , Silva, Akila De, Nijher, Gurjinder, Ganiyu‐Dada, Zainab, Mehta, Amrish, Todd, Catriona, Ghatei, Mohammad A., Bloom, Stephen R. , Dhillo, Waljit S. , Jayasena, Channa N, Jayasena, Channa N

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | February 11, 2014 | Volume: 99 | Issue: 6 | Pages: E953-E961

10.1210/jc.2013-1569 | PMID 24517142 Get It

The effects of N‐ethyl‐N′‐methyl imidazolium chloride on the solubility, stability and aggregation of tc‐rPA
Tischer, Alexander , Pultke, Heiko, Topf, Andrea, Auton, Matthew , Lange, Christian , Lilie, Hauke , Auton, Matthew , Tischer, Alexander

Mayo Clinic

The FEBS Journal | February 10, 2014 | Volume: 281 | Issue: 7 | Pages: 1738-1749

10.1111/febs.12736 | PMID 24506586 Get It

The ionic liquid N‐ethyl‐N′‐methyl imidazolium chloride (EMIMCl) has been described as being very efficient in promoting refolding of the recombinant plasminogen activator rPA. Our study reveals that molar concentrations of EMIMCl increase the solubility of native and unfolded proteins due to favorable interactions with amino acid side chains rather than favorably interacting with the peptide backbone. This delicate balance of favorable interactions with side chains and unfavorable interactions with the peptide backbone provides a molecular explanation of how EMIMCl suppresses protein aggregation and simultaneously promotes refolding. By contrast, high concentrations of EMIMCl denature proteins because of a reduced water content and strong favorable interactions with amino acid side chains. This denatured species is not soluble and aggregates because, in contrast to the classical denaturants, guanidine hydrochloride and urea, EMIMCl does not solubilize the peptide backbone.Structured digital abstract PNP and PNP bind by molecular sieving (1, 2, 3, 4)